Aberrant gut microbiota composition at the onset of type 1 diabetes in young children (Q35188386)

7 August 2017

title

Aberrant gut microbiota composition at the onset of type 1 diabetes in young children (English)

1 reference

Bartholomeus van den Bogert

7 August 2017

0 references

object named as

Bartholomeus van den Bogert

0 references

Heikki Hyöty

object named as

Heikki Hyöty

0 references

Willem de Vos

object named as

Willem M de Vos

1 reference

7 August 2017

Gjalt W Welling

1 reference

7 August 2017

Marcus C de Goffau

1 reference

7 August 2017

Susana Fuentes

1 reference

7 August 2017

Hanna Honkanen

1 reference

7 August 2017

Hermie J M Harmsen

1 reference

7 August 2017

publication date

15 June 2014

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

1 reference

7 August 2017

page(s)

1569-1577

1 reference

Fecal microbiota transplantation and emerging applications

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Role of the intestinal microbiome in health and disease: from correlation to causation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Diversity, stability and resilience of the human gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Microbes in gastrointestinal health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Gut microbiota, immunity, and disease: a complex relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Innate immunity and intestinal microbiota in the development of Type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Toward defining the autoimmune microbiome for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Fecal microbiota composition differs between children with β-cell autoimmunity and those without

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

The "perfect storm" for type 1 diabetes: the complex interplay between intestinal microbiota, gut permeability, and mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Interactions and competition within the microbial community of the human colon: links between diet and health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

The onset age of type 1 diabetes in Finnish children has become younger. The Finnish Childhood Diabetes Registry Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

The incidence of type 1 diabetes in the age group 0-39 years has not increased in Antwerp (Belgium) between 1989 and 2000: evidence for earlier disease manifestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Succession of microbial consortia in the developing infant gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Retracted: Butyrate Attenuates Lipopolysaccharide-Induced Inflammation in Intestinal Cells and Crohn's Mucosa through Modulation of Antioxidant Defense Machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Infections in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Streptococcus pneumoniae type 3 encodes a protein highly similar to the human glutamate decarboxylase (GAD65).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

The phylogeny of the genus Clostridium: proposal of five new genera and eleven new species combinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Taxonomy of the Clostridia: Ribosomal Ribonucleic Acid Homologies among the Species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Storage conditions of intestinal microbiota matter in metagenomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

Effect of storage conditions on the assessment of bacterial community structure in soil and human-associated samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-014-3274-0

The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998

21 January 2018

1 reference

12 December 2020

Improved extraction of PCR-quality community DNA from digesta and fecal samples

1 reference

12 December 2020

Human gut microbiome viewed across age and geography

1 reference

12 December 2020

Streptococcus group B (GBS)--characteristic, occurrence in children and adolescents with type 1 diabetes mellitus.

1 reference

12 December 2020

Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose

1 reference

12 December 2020

Differences in the gut microbiota of healthy children and those with type 1 diabetes

1 reference

12 December 2020

Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease

1 reference

12 December 2020

Antibiotic treatment partially protects against type 1 diabetes in the Bio-Breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?

1 reference

12 December 2020

Fecal microbiota imbalance in Mexican children with type 1 diabetes

1 reference

12 December 2020

10.1007/S00125-014-3274-0

Identifiers

DOI

1 reference

7 August 2017

1 reference